Synopsis of recent research by authors named "An-Li Yang"
- An-Li Yang's research focuses on the intersection of molecular biology and clinical applications, particularly in cancer immunotherapy and osteoporosis treatment, with a significant emphasis on microRNAs and their roles in disease mechanisms.
- The study titled "The clinicopathological significance and predictive value for immunotherapy of programmed death ligand-1 expression in Epstein-Barr virus-associated gastric cancer" analyzes the correlation between PD-L1 expression and clinical outcomes in gastric cancer patients, shedding light on potential predictive biomarkers.
- Yang's investigation into microRNA-210 reveals its critical role in regulating vascular endothelial growth factor (VEGF) expression and bone cell differentiation, suggesting therapeutic avenues for managing postmenopausal osteoporosis.*
